Where does Simon Fraser University rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Simon Fraser University ranks #5,797 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Simon Fraser University hold?

Simon Fraser University holds 59 US utility patents granted between 2015 and 2024, spanning 65 technology areas.

What is Simon Fraser University's Innovation Score?

Simon Fraser University has an Innovation Score of 56.7 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Simon Fraser University focus on?

Simon Fraser University's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 11 patents, ranking #1,740 of 6,058 assignees active in that subclass. Grants appear in 65 CPC subclasses total.

Is Simon Fraser University's patent grant rate increasing or decreasing?

Simon Fraser University's recent grant velocity is -41% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Simon Fraser University's patents?

Simon Fraser University's patents average 19.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Simon Fraser University patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Simon Fraser University

USPTO PatentsView assignee record - 59 granted patents across 65 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Simon ranks #5,797 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 65 technology areas.

#5,797
of 49,997 US assignees by volume: Top 6%
by Innovation Score (56.7/100): 19.6
avg claims per patent: -41%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5797 · Foreign Corporation #5,797 · 59 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 59 grants
UPPER-Q #5,797/49,997
PHOTO-FINISH Shanghai Institute…
CPC-WIDE A61P · 65 areas
INNOV-PAR 56.7/100
CLAIMS-RICH 19.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -41% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shanghai Institute of Optics And Fine Mechanics, Chinese Academy of Sciences (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Simon’s 56.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (25%) Velocity 5.8 pts (10%) Breadth 25.0 pts (44%) Claim depth 11.7 pts (21%)

Qualcomm Incorporated · highest

85
SEB · near

57
Aura Home · near

57
nference · near

57
Rehrig Pacific · near

57
Simon Fraser… · this assignee

57
3D Lighting… · lowest

7

What this shows Simon's Innovation Score is 56.7/100 (top 6% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Simon?

Each dot is one of Simon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Simon’s own 19.6 claims/patent is ABOVE the 15.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Simon vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Simon's grant cadence moved

Between 2020–2024, Simon Fraser University received 22 grants versus 37 in 2015–2019 (-41% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 13 grants and bottomed in 2024 at 3. Lead class A61P accounts for 18.6% of the portfolio across 65 subclasses. Volume neighbours: SI-Bone Inc. (#5,793) and The University of Western Australia (#5,801).

Simon's three-year grant acceleration

Simon Fraser University shows 13 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Si-bone

59
Sitting MAN

59
Shanghai Institut…

59
Silc

59
Spectra Logic

59
THE William M Yar…

59
Tela Innovations

59
The University of…

59
Simon Fraser Univ… ◀

59

What this shows Simon holds 59 patents at rank #5,797, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Simon

By rank, the assignees closest to #5,797 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Simon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Simon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Simon ranks #1,740 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (57 here).

Aura Home, Inc. 57 Rehrig Pacific Company 57 nference, Inc. 57 SEB S.A. 57

Similar claim depth

Nearest assignees by average claims per patent (19.6 here).

Canon U.S. Life Sciences, Inc. 19.6 avg Unity Technologies SF 19.6 avg THE Volcano Corporation 19.6 avg Paypal, Inc. 19.6 avg

Simon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

57 Top 6% higher than 94% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Simon Fraser University patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	13	22.0%
2016	8	13.6%
2017	6	10.2%
2018	4	6.8%
2019	6	10.2%
2020	5	8.5%
2021	4	6.8%
2022	6	10.2%
2023	4	6.8%
2024	3	5.1%

Which technologies does Simon Fraser University patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

A61B - DIAGNOSIS; SURGERY; Identification 11

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 10

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 9

C07D - Heterocyclic Compounds 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 8

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 8

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 8

C07C - Acyclic OR Carbocyclic Compounds 7

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 6

B01D - Separation 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 5

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 4

Top 15 of 65 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Simon Fraser University's patent record in context - here's where to go next.

Simon Fraser University's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 18.6% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #5,797 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Simon Fraser University against SI-Bone Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 56.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.